Published by MBA Skool Team, Last Updated: April 12, 2020
SWOT analysis of Actelion analyses the brand by its strengths, weaknesses, opportunities & threats. In Actelion SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Actelion to benchmark its business & performance as compared to the competitors. Actelion is one of the leading brands in the pharma and healthcare sector.
The article below lists the Actelion SWOT, competitors and includes its target market, segmentation, positioning & USP. Let us start the Actelion SWOT Analysis:
For Actelion, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position.
The strengths of Actelion looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value. Below are the Strengths in the SWOT Analysis of Actelion :
1. Actelion operates in niche segment of orphan diseases which have less competition
2. Strong presence in over 60 plus markets
3. Key drugs in the late stages of development in pipeline
4. Longer patent life of key drugs
5. Over 2500+ well trained employees
The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the Actelion SWOT Analysis:
1. Limited presence in emerging markets
2. They have only four blockbuster drugs
The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in Actelion SWOT Analysis:
1. Diversify portfolio in specialty diseases
2. Contract manufacturing of G.P diseases
3. Market introduction of Cadazolid
The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of Actelion are as mentioned:
1. Increasing pressure to reduce prices in Europe
2. Growing number of generic drugs
3. Global economic slowdown
There are several brands in the market which are competing for the same set of customers. Below are the top 4 competitors of Actelion:
Actelion operates in niche segment of orphan diseases
Orphan diseases such as digital ulcers, gaucher’s disease
Healthcare professionals operating in these areas
Actelion is company which blends biotechnological innovation with pharmaceutical discipline
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Actelion. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute